Spots Global Cancer Trial Database for doxorubicin adverse reaction
Every month we try and update this database with for doxorubicin adverse reaction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients | NCT06092606 | Cancer Heart Failure Arrhythmia Doxorubicin Ind... Doxorubicin Adv... | Control group:D... Trial group: DH... Trial group: DH... | 18 Years - 75 Years | Monyan Pharmaceutical (Shanghai) Co., Ltd. | |
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients | NCT06092606 | Cancer Heart Failure Arrhythmia Doxorubicin Ind... Doxorubicin Adv... | Control group:D... Trial group: DH... Trial group: DH... | 18 Years - 75 Years | Monyan Pharmaceutical (Shanghai) Co., Ltd. | |
The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor | NCT03505164 | Doxorubicin Adv... Cardiomyopathie... Breast Cancer | 18 Years - 64 Years | Rush University Medical Center |